Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I G M Lancisi G Salesi

Ancona 60126

1 studies enrolling now · 4 studies all time

What they study most

Advanced Malignancies, Chronic Myeloid Leukemia, Multiple Myeloma, NSCLC, Ovarian Cancer, Solid Tumors, Urothelial Cancer

Studies at this site

• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing — Running, not enrolling
• Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant — Running, not enrolling
• Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia — Status unconfirmed